German generic drug company Stada in early talks over possible $11B sale, exec confirms
Speculation has been swirling in recent weeks over whether the German generic drug company known as Stada might seek a sale worth about $11 billion …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
